1371 related articles for article (PubMed ID: 18080776)
1. Tetraiodothyroacetic acid, a small molecule integrin ligand, blocks angiogenesis induced by vascular endothelial growth factor and basic fibroblast growth factor.
Mousa SA; Bergh JJ; Dier E; Rebbaa A; O'Connor LJ; Yalcin M; Aljada A; Dyskin E; Davis FB; Lin HY; Davis PJ
Angiogenesis; 2008; 11(2):183-90. PubMed ID: 18080776
[TBL] [Abstract][Full Text] [Related]
2. Proangiogenic action of thyroid hormone is fibroblast growth factor-dependent and is initiated at the cell surface.
Davis FB; Mousa SA; O'Connor L; Mohamed S; Lin HY; Cao HJ; Davis PJ
Circ Res; 2004 Jun; 94(11):1500-6. PubMed ID: 15117822
[TBL] [Abstract][Full Text] [Related]
3. Nerve growth factor (NGF) promotes angiogenesis in the quail chorioallantoic membrane.
Lazarovici P; Gazit A; Staniszewska I; Marcinkiewicz C; Lelkes PI
Endothelium; 2006; 13(1):51-9. PubMed ID: 16885067
[TBL] [Abstract][Full Text] [Related]
4. Thyroid hormone and angiogenesis.
Luidens MK; Mousa SA; Davis FB; Lin HY; Davis PJ
Vascul Pharmacol; 2010; 52(3-4):142-5. PubMed ID: 19879961
[TBL] [Abstract][Full Text] [Related]
5. Tetraidothyroacetic acid (tetrac) and tetrac nanoparticles inhibit growth of human renal cell carcinoma xenografts.
Yalcin M; Bharali DJ; Lansing L; Dyskin E; Mousa SS; Hercbergs A; Davis FB; Davis PJ; Mousa SA
Anticancer Res; 2009 Oct; 29(10):3825-31. PubMed ID: 19846915
[TBL] [Abstract][Full Text] [Related]
6. Growth-regulated oncogene is pivotal in thrombin-induced angiogenesis.
Caunt M; Hu L; Tang T; Brooks PC; Ibrahim S; Karpatkin S
Cancer Res; 2006 Apr; 66(8):4125-32. PubMed ID: 16618733
[TBL] [Abstract][Full Text] [Related]
7. Thyroid hormone induced angiogenesis through the integrin αvβ3/protein kinase D/histone deacetylase 5 signaling pathway.
Liu X; Zheng N; Shi YN; Yuan J; Li L
J Mol Endocrinol; 2014 Jun; 52(3):245-54. PubMed ID: 24532656
[TBL] [Abstract][Full Text] [Related]
8. VEGF and inhibitors of TGFbeta type-I receptor kinase synergistically promote blood-vessel formation by inducing alpha5-integrin expression.
Liu Z; Kobayashi K; van Dinther M; van Heiningen SH; Valdimarsdottir G; van Laar T; Scharpfenecker M; Löwik CW; Goumans MJ; Ten Dijke P; Pardali E
J Cell Sci; 2009 Sep; 122(Pt 18):3294-302. PubMed ID: 19706683
[TBL] [Abstract][Full Text] [Related]
9. Pro-angiogenesis action of thyroid hormone and analogs in a three-dimensional in vitro microvascular endothelial sprouting model.
Mousa SA; Davis FB; Mohamed S; Davis PJ; Feng X
Int Angiol; 2006 Dec; 25(4):407-13. PubMed ID: 17164749
[TBL] [Abstract][Full Text] [Related]
10. Bortezomib mediates antiangiogenesis in multiple myeloma via direct and indirect effects on endothelial cells.
Roccaro AM; Hideshima T; Raje N; Kumar S; Ishitsuka K; Yasui H; Shiraishi N; Ribatti D; Nico B; Vacca A; Dammacco F; Richardson PG; Anderson KC
Cancer Res; 2006 Jan; 66(1):184-91. PubMed ID: 16397231
[TBL] [Abstract][Full Text] [Related]
11. Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia.
Ryu J; Lee CW; Hong KH; Shin JA; Lim SH; Park CS; Shim J; Nam KB; Choi KJ; Kim YH; Han KH
Cardiovasc Res; 2008 May; 78(2):333-40. PubMed ID: 18006432
[TBL] [Abstract][Full Text] [Related]
12. Nobiletin, a citrus polymethoxyflavonoid, suppresses multiple angiogenesis-related endothelial cell functions and angiogenesis in vivo.
Kunimasa K; Ikekita M; Sato M; Ohta T; Yamori Y; Ikeda M; Kuranuki S; Oikawa T
Cancer Sci; 2010 Nov; 101(11):2462-9. PubMed ID: 20670297
[TBL] [Abstract][Full Text] [Related]
13. PPAR gamma ligands, rosiglitazone and pioglitazone, inhibit bFGF- and VEGF-mediated angiogenesis.
Aljada A; O'Connor L; Fu YY; Mousa SA
Angiogenesis; 2008; 11(4):361-7. PubMed ID: 18810647
[TBL] [Abstract][Full Text] [Related]
14. Endothelial cell response to lactate: implication of PAR modification of VEGF.
Kumar VB; Viji RI; Kiran MS; Sudhakaran PR
J Cell Physiol; 2007 May; 211(2):477-85. PubMed ID: 17167776
[TBL] [Abstract][Full Text] [Related]
15. Identification and functions of the plasma membrane receptor for thyroid hormone analogues.
Lin HY; Cody V; Davis FB; Hercbergs AA; Luidens MK; Mousa SA; Davis PJ
Discov Med; 2011 Apr; 11(59):337-47. PubMed ID: 21524387
[TBL] [Abstract][Full Text] [Related]
16. Blockade of EphA receptor tyrosine kinase activation inhibits vascular endothelial cell growth factor-induced angiogenesis.
Cheng N; Brantley DM; Liu H; Lin Q; Enriquez M; Gale N; Yancopoulos G; Cerretti DP; Daniel TO; Chen J
Mol Cancer Res; 2002 Nov; 1(1):2-11. PubMed ID: 12496364
[TBL] [Abstract][Full Text] [Related]
17. Tetraiodothyroacetic acid (tetrac) and nanoparticulate tetrac arrest growth of medullary carcinoma of the thyroid.
Yalcin M; Dyskin E; Lansing L; Bharali DJ; Mousa SS; Bridoux A; Hercbergs AH; Lin HY; Davis FB; Glinsky GV; Glinskii A; Ma J; Davis PJ; Mousa SA
J Clin Endocrinol Metab; 2010 Apr; 95(4):1972-80. PubMed ID: 20133461
[TBL] [Abstract][Full Text] [Related]
18. Contextual role for angiopoietins and TGFbeta1 in blood vessel stabilization.
Ramsauer M; D'Amore PA
J Cell Sci; 2007 May; 120(Pt 10):1810-7. PubMed ID: 17502485
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor binding protein-7 (IGFBP7) blocks vascular endothelial cell growth factor (VEGF)-induced angiogenesis in human vascular endothelial cells.
Tamura K; Hashimoto K; Suzuki K; Yoshie M; Kutsukake M; Sakurai T
Eur J Pharmacol; 2009 May; 610(1-3):61-7. PubMed ID: 19374835
[TBL] [Abstract][Full Text] [Related]
20. Tetraiodothyroacetic acid and its nanoformulation inhibit thyroid hormone stimulation of non-small cell lung cancer cells in vitro and its growth in xenografts.
Mousa SA; Yalcin M; Bharali DJ; Meng R; Tang HY; Lin HY; Davis FB; Davis PJ
Lung Cancer; 2012 Apr; 76(1):39-45. PubMed ID: 22024450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
